Leerink Partnrs Weighs in on AQST Q2 Earnings
Aquestive Therapeutics, Inc. (NASDAQ:AQST – Free Report) – Leerink Partnrs issued their Q2 2025 earnings per share (EPS) estimates for shares of Aquestive Therapeutics in a research report issued to clients and investors on Tuesday, May 13th. Leerink Partnrs analyst R. Ruiz anticipates that the company will post earnings of ($0.17) per share for the […]
